Table 4.
GCLC GAG TNR genotypes in the Danish sample
| Genotypes | Controls |
Patients |
OR | 95% CI | P value | ||
|---|---|---|---|---|---|---|---|
| N | % | N | % | ||||
| 7/7 | 125 | 37.8 | 87 | 27.0 | 0.61 | 0.43–0.85 | 0.003 |
| 7/8 | 65 | 19.6 | 64 | 19.9 | 1.02 | 0.69–1.49 | 0.939 |
| 7/9 | 86 | 26.0 | 103 | 32.0 | 1.34 | 0.95–1.88 | 0.091 |
| 8/8 | 8 | 2.4 | 22 | 6.8 | 2.96 | 1.30–6.75 | 0.007 |
| 8/9 | 27 | 8.2 | 19 | 5.9 | 0.71 | 0.38–1.30 | 0.260 |
| 9/9 | 20 | 6.0 | 27 | 8.4 | 1.42 | 0.78–2.59 | 0.247 |
| Controls vs. patients: (125, 65, 86, 8, 27, and 20 vs. 87, 64, 103, 22, 19, and 27)* | 0.004 | ||||||
N, number of genotypes in a group; %, percentage of genotypes in a group. Data are given together with OR and 95% confidence interval (CI). P values were calculated using χ2 test (two-tailed).
*The frequency of genotypes between patients and controls was compared using χ 2 test (two-tailed) with a 2 × 6 contingency table (controls and patients × genotypes 7/7, 7/8, 7/9, 8/8, 8/9, and 9/9).